Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FEWFD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,108
Award facts
- Contract value 100% obligated
- $16,107.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,107.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract involves no set-aside designation and is competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its expansive federal contract portfolio to supply critical medications to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery of Zepbound, a GLP-1 receptor agonist medication used for weight management, reflects the company's capability to fulfill specialized pharmaceutical procurement requirements for federal medical supply chains. As a non-set-aside, competitively awarded contract, this order underscores AmerisourceBergen's continued role as a primary vendor for DLA's medical supply operations and its ability to meet federal healthcare demands across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FEWFD?
SPE2DB25FEWFD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FEWFD worth?
The government has obligated $16,108 on SPE2DB25FEWFD.
Is contract SPE2DB25FEWFD an order under another contract?
Yes. SPE2DB25FEWFD is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FEWFD competed?
The extent of competition for SPE2DB25FEWFD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award